Failure of protection induced by a Brazilian vaccine against Brazilian wild rabies viruses

Archives of Virology

Volumn 143, Issue 9, 1998, Pages 1745-1756

  Zanetti, C R ^a   De Franco, M T ^b   Vassao R C ^b   Pereira, C A ^b   Pereira, O A C ^a  

^a Instituto Pasteur de Sao Paulo   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BRAZIL; RABIES VIRUS; VACCINATION;

ANIMALS; BRAZIL; HUMANS; IMMUNIZATION; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; RABIES; RABIES VIRUS;

ANIMALIA; RABIES VIRUS;

EID: 0031685407     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050413     Document Type: Article

References (29)

1. Bourhy H, Kissi B, Tordo N (1993) Molecular diversity of the Lyssavirus genus. Virology 194: 70-81
2. Dietzschold B, Rupprecht CE, Tollis M, Mattel J, Wiktor TK, Koprowski H (1988) Antigenic diversity of the glycoprotein and nucleocapsid proteins of rabies and rabies-related viruses: implications for epidemiology and control of rabies. Rev Infect Dis 10: 5 785-5 798
3. Germano PML, Silva EV, Sureau P (1978) Determinação do perfil antigênico de 3 cepas de vírus rábico, isolados no Brasil, através de técnica dos anticorpos monoclonais antinucleocapside. Rev Fac Med Vet Zootec Univ S Paulo 225: 199-205
4. Larghi OP (1989) Conceptos generales sobre rabia. In: Congresso de Ciencias Veterinárias. Foro Internacional sobre Rabia. Maracaibo, Venezuela, pp 11-22
5. Wiktor TJ (1985) Les anticorps monoclonaus: application à l'étude de la rage. In: FRANCE. Ministére de l'Agriculture. Pasteur et la rage. Paris, pp. 139-S144-S. (Informations Techiniques de Services Vétérinaires, 92-95)
6. Blancou J, Andral L, Mannen K (1981) Anticorps monoclonaux et rage: variantes antigéniques de souches de virus sauvages en France. Joint CNER-WHO Scientific Meeting on Animal Rabies. Nancy and Malzeville
7. Lafon M, Bourhy H, Sureau P (1988) Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccine an experimental study in mice. Vaccine 6: 362-368
8. Wiktor TJ, MacFarlan R, Foggin C, Koprowski H (1984) Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies. Dev Biol Standards 57: 199-211
9. Wiktor TJ (1982) Introduction á l'étude des variantes antigéniques du virus rabique. Comp Immunol Microbbiol Infect Dis 5: 93-94
10. Hayashi Y, Mora E, Chandelier EL, Montaño JA, Ohi M (1984) Estudos de proteção cruzada de 24 cepas de vírus rábico isoladas de diferentes espécimes animais do Brasil. Arq Biol Tecnol 27: 27-35
11. Cordeiro CC, Silva EV, Miguel O, Germano PML (1990) Avaliação da vacina antirábica ERA, frente a variantes antigênicas do vírus da raiva, em diferentes períodos pós imunização. Rev Saúde Pública S Paulo 24: 512-517
12. Erbolato EB, Vieira DA, Silva E, Miguel O, Sureau P, Germano PML (1989) Eficácia da vacina anti-rábica ERA em camundongos, frente a quatro diferentes variantes do vírus da raiva. Rev Saúde Públ S Paulo 23: 447-454
13. Fuenzalida E, Palacios R (1955) Un método mejorado en la preparación de la vacuna antirrábica. Bol Inst Bact Chile 8: 3-10
14. Wilbur LA, Aubbert MFA (1996) The NIH test for potency. In: Meslin F-X, Kaplan MM, Koprowski H ed. Laboratory techniques in rabies, 4th ed. World Health Organization, Geneva, pp 360-368
15. Habel K (1996) Habel test for potency. In: Meslin F-X, Kaplan MM, Koprowski H (ed.) Laboratory techniques in rabies, 4th ed. World Health Organization, Geneva, pp 369-373
16. Aubert MFA (1996) Methods for the calculation of titers. In: Meslin F-X, Kaplan MM, Koprowski H (ed.) Laboratory techniques in rabies, 4th ed. World Health Organization, Geneva, pp 445-459
17. Fuenzalida E, Larghi O (1972) Características de una cepa de virus rábico aislada del cérebro de Desmodus rotundus rotundus. Bol Ofic San Pan 73: 93-99
18. Perrin P, Tino DE, Franco M, Jallet C, Fouque F, Morgeaux S, Tordo N, Colle J-H (1996) The antigen-specific cell-mediated immune response in mice is suppressed by infection with pathogenic lyssaviruses. Res Virol 147: 289-299
19. Favoretto SR, Carrieri ML, Tino MS, Zanetti CR, Pereira OAC (1993) Simplified fluorescence inhibition microtest for titration of rabies neutralising antibodies. Rev Inst Med Trop São Paulo 35: 171-175
20. Pereira CA, Mercier GM, Oth D, Dupuy JM (1984) Induction of natural killer cells and interferon during mouse hepatitis virus infection of resistant and susceptible inbred mouse strains. Immunobiology, 166: 35-44
21. Walker SM, Morgan EL, Weigle WO (1981) Regulation of the "in vitro" secondary antibody response 2. Antigen-induced murine splenic T cell proliferation. J Immunol 126: 766-769
22. Perrin P, Versmisse P, Delagneau J-F, Lucas G, Rollin P, Sureau P (1986) The influence of immunosorbent on rabies antibody EIA; advantages of purified glycoprotein. J Biol Standards 14: 95-102
23. Perrin P, Joffret M-L, Zanetti CR, Bourhy H, Gontier C, Fritzell C, Leclerc C, Sureau P (1991) Rabies-specific production of interleukin-2 by peripheral blood lymphocytes from human rabies vaccinees. Vaccine 9: 549-558
24. Zinkernagel R, Doherty P (1979) MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv Immunol 27: 51-177
25. Unanue E (1984) Antigen-presenting function of the macrophage. Annu Rev Immunol 2: 395-428
26. Elliott T, Townsend A, Cerndolo V (1990) Naturally processed peptides. Nature 348: 195-197
27. Harding C (1991) Pathway of antigen processing. Curr Opin Immunol 3: 3-9
28. Mosmann T, Coffman R (1989) TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145-173
29. Zanetti CR, Chaves LB, Silva ACR, Lee LM, Pereira OAC (1995) Studies on human anti-rabies immunization in Brazil. I-Evaluation of the 3+1 pre-exposure vaccination schedule under field conditions. Rev Inst Med Trop São Paulo 37: 349-352